Orion Oyj Series A | Mutual Funds
Mutual Funds that own Orion Oyj Series A
Ilmarinen Mutual Pension Insurance
3,008,794
8.11%
1,034,099
0.22%
12/31/2017
DFA Continental Small Company Series
123,563
0.33%
0
0.07%
01/31/2018
Nordea Finnish Index Fund
80,173
0.22%
11,822
0.87%
05/31/2018
36,700
0.1%
36,700
0.66%
12/31/2016
DFA International Core Equity Portfolio
35,936
0.1%
2,061
0.01%
04/30/2018
TD Emerald International Equity Index Fund
23,669
0.06%
-433
0.03%
12/31/2017
Metropolitan Series - Met/Dimensional Intl. Small Company Por.
8,256
0.02%
-532
0.05%
03/31/2018
Russell Investment Company II Plc - Pan European Equity (The)
7,971
0.02%
-1,611
0.05%
09/30/2017
DFA International Vector Equity Portfolio
7,528
0.02%
1,076
0.01%
04/30/2018
Dimensional Funds Plc - European Small Companies Fund
7,398
0.02%
3,595
0.13%
11/30/2017
| Address |
Orionintie 1A
Espoo UU 02200
Finland
|
|
Employees
|
- |
| Website |
http://www.orion.fi |
| Updated |
07/08/2019 |
| Orion Oyj engages in the development of pharmaceutical and diagnostic test. It develops, manufactures, and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Its pharmaceutical research and development focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. |
